SAB Biotherapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 05/20/2026 | 11.42 M | $43.74 M | 0.00% | 59.13% |
| CALIGAN PARTNERS LP | 05/15/2026 | 7.97 M | $30.51 M | 100.00% | 41.26% |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 6.43 M | $24.63 M | 700.75% | 33.30% |
| RA CAPITAL MANAGEMENT, L.P. | 05/15/2026 | 4.40 M | $16.86 M | 0.00% | 22.79% |
| COMMODORE CAPITAL LP | 05/15/2026 | 4.40 M | $16.86 M | 0.00% | 22.79% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 3.76 M | $14.40 M | 690.94% | 19.47% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 3.41 M | $13.04 M | 100.00% | 17.63% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 3.03 M | $11.62 M | 835.76% | 15.70% |
| WOODLINE PARTNERS LP | 05/15/2026 | 2.85 M | $10.92 M | 0.03% | 14.77% |
| 05/15/2026 | 2.49 M | $9.55 M | 100.00% | 12.91% | |
| 05/14/2026 | 2.20 M | $8.42 M | 0.00% | 11.38% | |
| SESSA CAPITAL IM, L.P. | 05/15/2026 | 2.20 M | $8.42 M | 0.00% | 11.38% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 1.48 M | $5.67 M | 100.00% | 7.67% |
| AMERIPRISE FINANCIAL INC | 05/15/2026 | 1.48 M | $5.65 M | 420.41% | 7.64% |
| ENSIGN PEAK ADVISORS, INC | 05/13/2026 | 1.38 M | $5.27 M | 100.00% | 7.12% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 1.05 M | $4.02 M | 100.00% | 5.44% |
| PROPEL BIO MANAGEMENT, LLC | 05/14/2026 | 1.01 M | $3.89 M | 55.13% | 5.24% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 903.09 K | $3.46 M | 55.62% | 4.68% |
| BLACKSTONE INC. | 05/15/2026 | 860.17 K | $3.29 M | -59.87% | 4.45% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 05/14/2026 | 768.63 K | $2.94 M | 792.58% | 3.98% |
| AFFINITY ASSET ADVISORS, LLC | 05/14/2026 | 575.00 K | $2.20 M | 100.00% | 2.98% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 05/13/2026 | 500.00 K | $1.92 M | 100.00% | 2.59% |
| MARSHALL WACE, LLP | 05/15/2026 | 463.93 K | $1.78 M | 96.20% | 2.40% |
| AWM INVESTMENT COMPANY, INC. | 05/15/2026 | 400.00 K | $1.53 M | 100.00% | 2.07% |
| DV TRADING LLC | 05/15/2026 | 400.00 K | $1.53 M | 100.00% | 2.07% |
| STEMPOINT CAPITAL LP | 05/18/2026 | 375.00 K | $1.44 M | 155.87% | 1.94% |
| HB WEALTH MANAGEMENT, LLC | 04/27/2026 | 307.50 K | $1.18 M | 0.00% | 1.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 302.04 K | $1.16 M | 152.71% | 1.56% |
| BLACKROCK, INC. | 05/13/2026 | 301.33 K | $1.15 M | 1,647.93% | 1.56% |
| SEVEN GRAND MANAGERS, LLC | 05/06/2026 | 275.00 K | $1.05 M | 100.00% | 1.42% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 197.62 K | $756.88 K | 100.00% | 1.02% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 187.23 K | $717.09 K | -10.08% | 0.97% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 181.19 K | $693.94 K | 100.00% | 0.94% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 113.94 K | $436.39 K | 121.90% | 0.59% |
| 06/04/2026 | 100.00 K | $383.00 K | 100.00% | 0.52% | |
| STATE STREET CORP | 05/15/2026 | 74.23 K | $284.31 K | 465.70% | 0.38% |
| JANE STREET GROUP, LLC | 05/12/2026 | 72.10 K | $276.14 K | 100.00% | 0.37% |
| PERSISTENT ASSET PARTNERS LTD | 05/12/2026 | 69.73 K | $267.07 K | 252.36% | 0.36% |
| KESTRA ADVISORY SERVICES, LLC | 04/30/2026 | 61.74 K | $236.47 K | 434.55% | 0.32% |
| BREVAN HOWARD CAPITAL MANAGEMENT LP | 05/15/2026 | 59.16 K | $226.59 K | 100.00% | 0.31% |
| NORTHERN TRUST CORP | 05/14/2026 | 57.43 K | $219.94 K | 249.90% | 0.30% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 55.70 K | $213.32 K | 424.80% | 0.29% |
| PATHSTONE HOLDINGS, LLC | 05/11/2026 | 50.65 K | $193.99 K | 0.00% | 0.26% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 50.00 K | $191.50 K | 100.00% | 0.26% |
| UBS GROUP AG | 05/05/2026 | 46.62 K | $178.57 K | 530.21% | 0.24% |
| FIFTH LANE CAPITAL, LP | 05/15/2026 | 46.50 K | $178.10 K | 210.00% | 0.24% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 46.46 K | $177.92 K | 100.00% | 0.24% |
| CITADEL ADVISORS LLC | 05/15/2026 | 42.90 K | $164.31 K | 100.00% | 0.22% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 37.94 K | $145.00 K | 100.00% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 05/15/2026 | 37.46 K | $143.45 K | 100.00% | 0.19% |
SAB Biotherapeutics Inc institutional Ownership - FAQ's
During the previous two years, 83 institutional investors and hedge funds held shares of SAB Biotherapeutics Inc. The most heavily invested institutionals were:
Vivo Capital, LLC: 11.42 M
Caligan Partners LP: 7.97 M
PERCEPTIVE ADVISORS LLC: 6.43 M
RA CAPITAL MANAGEMENT, L.P.: 4.4 M
COMMODORE CAPITAL LP: 4.4 M
BALYASNY ASSET MANAGEMENT L.P.: 3.76 M
358.29% of SAB Biotherapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 67.30 M shares in the last 24 months. This purchase volume represents approximately $258.44 M in transactions.